期刊文献+

红细胞输血反应及输注合理性临床分析 被引量:3

原文传递
导出
摘要 目的探讨临床输注红细胞发生的输血反应及输注的合理性。方法在输血前向医院发放输血反应单,根据病历中患者的输血记录、手术用血记录、实验室相关检测结果等资料判定输血反应类型及红细胞输注是否合理。结果郑州市17家医院输注红细胞发生输血反应69例,其中发热33例,过敏26例,呼吸困难5例,迟发性溶血反应2例,TRAIL1例。结论此次调查结果显示,红细胞输注存在不合理性。为减少输血反应,采用滤除白细胞的红细胞,对免疫你下的患者可使用辐照血,对反复多次输血的患者可采用洗涤红细胞,同时加强献血。
作者 王兆福
出处 《医药论坛杂志》 2011年第17期138-139,共2页 Journal of Medical Forum
  • 相关文献

参考文献3

  • 1杨崇礼 阎石.输血不良反应发生机制与防治[A].见杨成民 李家增 季阳主编.基础输血学[C].中国科学技术出版社,2001.448.
  • 2Ware LB, Matthay MA. The acute respiratory distress syndrome[J]. N Engl J Med,2000,342(3):1334-1349.
  • 3董秀娟,赛亚,赵晓武,陈蕾,马红霞,贾利红.输血相关急性移植物抗宿主病2例[J].中国输血杂志,2008,21(3):202-203. 被引量:5

二级参考文献8

  • 1Aoun E, Shamseddine A. Transfusion-associated GVHD: 10 years, experience at the American University of Beirut-Medical Center[ J]. Transfusion,2003,43 (12) : 1672-1682.
  • 2Oto OA, Pavdas S. Transfusion-associated graft-versus-host disease[ J]. Eur J Intern Med. 2006 ,17(3) :151-163.
  • 3Bojanic I, Cepulic BG. Transfusion-associated graft-versus-host disease [J]. Lijec Vjesn,2004,126(1-2) :39-475.
  • 4Anwar M, Bhatti FA. Transfusion associated graft versus host disease [J]. J Ayub Med Coil Abottabad. ,2003,15(3) :56-86.
  • 5Wagner FF. Transfusion-associated graft-versus-host disease:risk due to homozygous HLA haplotypes [J]. Transfusion, 1995,35 : 284-291.
  • 6Hutchinson K, Kopko PM. Early diagnosis and successful treatment of a patient with transfusion-asscciated GVHD with autologous peripheral blood progenitor cell transplantation[J]. Transfusion ,2002,42(12) :1567-1572.
  • 7Gupta A, Bansal D. Transfusion-associated graft-versus-host disease [J]. Indian Pedlatr,2004,41 (12) :1260-1264.
  • 8Moriyama S, Kurihara K. Evaluation of absorbed dose-distribution in the X-ray or gamma-irradiator for blood products [ J ]. Yakugaku Zasshi, 2001,121 (4) : 283 -288

共引文献10

同被引文献41

  • 1吕运来,贠中桥,兰炯采,孙先玲,杨波,张艳艳.红细胞无效输注回顾性初探[J].中国输血杂志,2007,20(3):220-221. 被引量:70
  • 2Pettila V,Westbrook AJ,Nichol AD,et al. Age of red blood cells and mortality in the critically ill[ J]. Crit Care,2011,15(2) :R116.
  • 3Triulzi DJ, Yazer MH. Clinical studies of the effect of blood storage on patient outcomes[ J]. Transfus Apher Sci,2010,43(1) ;95-106.
  • 4Ness PM. Does transfusion of stored red blood cells cause clinically important adverse effects? A critical question in search of an answer and a plan[ J]. Transfusion,2011,51 (4) ;666-667.
  • 5Hess JR. Red cell changes during storage [ J]. Transfus Apher Sci, 2010,43(1) :51-59.
  • 6Madjdpour C, Heindl V, Spahn DR. Risks, benefits, alternatives and indications of allogenic blood transfusions [ J ]. Minerva Anestesiol, 2006,72(5) :283-298.
  • 7Ozment CP,Mamo LB,Campbell ML,et al. Transfusion-related biologic effects and free hemoglobin,heme,and iron[ J]. Transfusion,2013, 5(4);732-740.
  • 8Muhoz M,Garcla-Erce JA,Remacha AF, et al. Disorders of iron metabolism. Part 1 :molecular basis of iron homoeostasi[ J]. J Clin Pathol, 2011,64(4) :281-286.
  • 9Cherayil BJ. Iron and immunity: immunological consequences of iron deficiency and overload [ J ]. Arch Immunol Ther Exp ( Warsz), 2010,58(6):407^15.
  • 10Reddy PV,Puri RV, Khera A,et al. Iron storage proteins are essentialfor the survival and pathogenesis of Mycobacterium tuberculosis in THP-1 macrophages and the guinea pig model of infection[ J] . J Bacteriol,2012,194(3) :567-575.

引证文献3

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部